VITRAFY LIFE SCIENCES LIMITED (VFY)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for VFY during the last 90 days, indicating Moderate trading activity

Latest VFY Signals
04/06/2026	BUY
23/03/2026	SELL
22/03/2026	SELL
VFY Share Price
Current Price	$3.120
52 Week High	$3.800
52 Week Low:	$1.160
Trading at (% of 52 Week High)	82.11%

Business Overview

Vitrafy Life Sciences Limited (ASX: VFY) is an Australian company that develops and markets health and wellness products. The company focuses on innovative solutions in the life sciences sector to improve health outcomes.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for VITRAFY LIFE SCIENCES LIMITED (VFY) is supported by current market trends and potential growth in the life sciences sector. However, the relatively low stock price and limited available data introduce moderate uncertainty, warranting a cautious approach.

Latest  VITRAFY LIFE SCIENCES LIMITED(VFY)   News